EVAX

$0.00

(

+0.00%

)
Quote details

stock

Evaxion Biotech AS

NASDAQ | EVAX

6.45

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 11, 2025)

$53.13M

Market Cap

-

P/E Ratio

-4

EPS

$12.15

52 Week High

$1.20

52 Week Low

HEALTHCARE

Sector

EVAX Chart

Recent Chart
Price Action

EVAX Technicals

Tags:

EVAX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $3.3M
Total Revenue $3.3M
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$15M
Selling General And Administrative $7.3M
Research And Development $10M
Operating Expenses $18M
Investment Income Net -
Net Interest Income -$708K
Interest Income $254K
Interest Expense $962K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $607K
Income Before Tax -$11M
Income Tax Expense -$788K
Interest And Debt Expense -
Net Income From Continuing Operations -$11M
Comprehensive Income Net Of Tax -
Ebit -$10M
Ebitda -$9.8M
Net Income -$11M

Revenue & Profitability

EVAX Financials

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $3.3M
Total Revenue $3.3M
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$15M
Selling General And Administrative $7.3M
Research And Development $10M
Operating Expenses $18M
Investment Income Net -
Net Interest Income -$708K
Interest Income $254K
Interest Expense $962K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $607K
Income Before Tax -$11M
Income Tax Expense -$788K
Interest And Debt Expense -
Net Income From Continuing Operations -$11M
Comprehensive Income Net Of Tax -
Ebit -$10M
Ebitda -$9.8M
Net Income -$11M

EVAX News

EVAX Profile

Evaxion Biotech AS Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Evaxion Biotech AS (EVAX) is a pioneering clinical-stage biopharmaceutical company based in Hørsholm, Denmark, leveraging advanced artificial intelligence to drive innovation in immunotherapy. With a strategic focus on addressing unmet medical needs in oncology, bacterial diseases, and viral infections, the company utilizes its proprietary platform to identify and develop novel therapeutic candidates. As Evaxion progresses its diverse pipeline, it aims to transform treatment paradigms and enhance patient outcomes, establishing itself as a significant force within the biotechnology industry.

ATPC
+164.70%
$0.18
LPTX
+368.57%
$2.05
NVDA
-1.55%
$180.93
WOK
-11.52%
$0.16
PAVS
-9.21%
$0.03
VSME
+11.42%
$0.09
PETS
+68.36%
$2.98
RZLT
-87.20%
$1.40
YGMZ
-61.42%
$0.02
PLUG
+4.42%
$2.36
ORCL
-10.83%
$198.85
RIVN
-6.11%
$16.43
ASST
-7.82%
$0.92
VIVK
+14.55%
$0.07
URG
-8.08%
$1.25
KIND
+9.48%
$2.77
NXDR
+9.48%
$2.77
AXDX
-61.36%
$0.03
IVP
-12.52%
$0.05
ONDS
+8.34%
$9.02
IRBT
-4.58%
$5.00
INTC
-3.11%
$39.51
F
+1.64%
$13.63
MIGI
-8.95%
$6.10
TSLA
-1.01%
$446.89
KVUE
0.00%
$17.32
BTTC
+24.28%
$4.12
ADAP
-15.14%
$0.05
DNN
+2.60%
$2.76
AAL
-1.18%
$14.96
AVGO
-1.59%
$406.37
HOOD
-9.05%
$123.38
MARA
-0.67%
$11.84
NFLX
+1.48%
$94.09
TE
-4.55%
$5.87
K
-0.01%
$83.44
SOND
-23.45%
$0.12
GOOGL
-2.42%
$312.43
SOFI
-0.07%
$27.07
BMNR
-5.00%
$38.38
WBD
-0.13%
$29.49
BTG
0.00%
$4.68
RR
+12.77%
$4.68
VALE
+2.30%
$13.29
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
T
-0.36%
$24.30
RGTI
+2.90%
$26.88
BYND
-4.06%
$1.18
ADD
-25.47%
$0.05
NIO
+1.98%
$5.13
PLTR
-0.19%
$187.54
BAC
+0.88%
$54.56
SRM
+53.27%
$10.30
PFE
+0.07%
$25.80
HL
+12.56%
$19.35
ASBP
+22.50%
$0.10
PLTD
+0.15%
$6.32
AAPL
-0.26%
$278.03
GRAB
0.00%
$5.18
BITF
0.00%
$2.94
HPE
-2.85%
$24.54
RIG
-0.46%
$4.28
RKLB
+10.44%
$63.53
JBLU
-2.78%
$4.89
QBTS
+4.40%
$27.98
AMD
+0.00%
$221.43
BMNU
-10.03%
$10.22
CIFR
+2.16%
$18.88
NGD
+9.19%
$8.55
ACHR
+2.27%
$8.56
AG
+7.13%
$16.81
CDE
+9.45%
$17.48
AMZN
-0.64%
$230.28
MTSR
-0.35%
$70.50
BBD
+2.71%
$3.41
BTBT
+4.23%
$2.46
SNAP
-3.53%
$7.64
CRWV
-0.88%
$87.38
IREN
+0.04%
$43.94
NCLH
+6.80%
$20.55
ABEV
+2.04%
$2.50
FI
+2.38%
$68.16
GOOG
-2.27%
$313.70
NOK
+2.25%
$6.36
MSFT
+1.02%
$483.47
HBAN
+1.99%
$17.91
CCL
+5.93%
$27.84
PCG
-1.65%
$14.83
AFMD
-34.94%
$0.18
KO
-1.56%
$69.11
SMCI
-2.52%
$34.02
WULF
+0.44%
$15.83
LUV
+2.28%
$40.74
UBER
+1.52%
$85.44
CNQ
-1.72%
$33.14
SOUN
-1.47%
$12.03
SMR
+4.42%
$21.22
CHR
-5.72%
$0.04
CLSK
+1.99%
$14.82
ATPC
+164.70%
$0.18
LPTX
+368.57%
$2.05
NVDA
-1.55%
$180.93
WOK
-11.52%
$0.16
PAVS
-9.21%
$0.03
VSME
+11.42%
$0.09
PETS
+68.36%
$2.98
RZLT
-87.20%
$1.40
YGMZ
-61.42%
$0.02
PLUG
+4.42%
$2.36
ORCL
-10.83%
$198.85
RIVN
-6.11%
$16.43
ASST
-7.82%
$0.92
VIVK
+14.55%
$0.07
URG
-8.08%
$1.25
KIND
+9.48%
$2.77
NXDR
+9.48%
$2.77
AXDX
-61.36%
$0.03
IVP
-12.52%
$0.05
ONDS
+8.34%
$9.02
IRBT
-4.58%
$5.00
INTC
-3.11%
$39.51
F
+1.64%
$13.63
MIGI
-8.95%
$6.10
TSLA
-1.01%
$446.89
KVUE
0.00%
$17.32
BTTC
+24.28%
$4.12
ADAP
-15.14%
$0.05
DNN
+2.60%
$2.76
AAL
-1.18%
$14.96
AVGO
-1.59%
$406.37
HOOD
-9.05%
$123.38
MARA
-0.67%
$11.84
NFLX
+1.48%
$94.09
TE
-4.55%
$5.87
K
-0.01%
$83.44
SOND
-23.45%
$0.12
GOOGL
-2.42%
$312.43
SOFI
-0.07%
$27.07
BMNR
-5.00%
$38.38
WBD
-0.13%
$29.49
BTG
0.00%
$4.68
RR
+12.77%
$4.68
VALE
+2.30%
$13.29
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
T
-0.36%
$24.30
RGTI
+2.90%
$26.88
BYND
-4.06%
$1.18
ADD
-25.47%
$0.05
NIO
+1.98%
$5.13
PLTR
-0.19%
$187.54
BAC
+0.88%
$54.56
SRM
+53.27%
$10.30
PFE
+0.07%
$25.80
HL
+12.56%
$19.35
ASBP
+22.50%
$0.10
PLTD
+0.15%
$6.32
AAPL
-0.26%
$278.03
GRAB
0.00%
$5.18
BITF
0.00%
$2.94
HPE
-2.85%
$24.54
RIG
-0.46%
$4.28
RKLB
+10.44%
$63.53
JBLU
-2.78%
$4.89
QBTS
+4.40%
$27.98
AMD
+0.00%
$221.43
BMNU
-10.03%
$10.22
CIFR
+2.16%
$18.88
NGD
+9.19%
$8.55
ACHR
+2.27%
$8.56
AG
+7.13%
$16.81
CDE
+9.45%
$17.48
AMZN
-0.64%
$230.28
MTSR
-0.35%
$70.50
BBD
+2.71%
$3.41
BTBT
+4.23%
$2.46
SNAP
-3.53%
$7.64
CRWV
-0.88%
$87.38
IREN
+0.04%
$43.94
NCLH
+6.80%
$20.55
ABEV
+2.04%
$2.50
FI
+2.38%
$68.16
GOOG
-2.27%
$313.70
NOK
+2.25%
$6.36
MSFT
+1.02%
$483.47
HBAN
+1.99%
$17.91
CCL
+5.93%
$27.84
PCG
-1.65%
$14.83
AFMD
-34.94%
$0.18
KO
-1.56%
$69.11
SMCI
-2.52%
$34.02
WULF
+0.44%
$15.83
LUV
+2.28%
$40.74
UBER
+1.52%
$85.44
CNQ
-1.72%
$33.14
SOUN
-1.47%
$12.03
SMR
+4.42%
$21.22
CHR
-5.72%
$0.04
CLSK
+1.99%
$14.82

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.